Drawing for EXFODERM

USPTO serial 74370232

EXFODERM

Reviewed by CopyMark Law Group

Status 607
Filing date
Status date
Registration date
—
Examiner
REIHNER, DAVID
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EXFODERM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003skin care products; namely, an exfoliating creamABANDONEDJan 1, 1994

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 12, 1995PCDEPETITION TO DIRECTOR DENIED—
Oct 3, 1994PCRCPETITION TO DIRECTOR RECEIVED—
Jun 24, 1994IUFFUSE AFFIDAVIT FAILED FORMALITIES—
May 17, 1994ABN7ABANDONMENT - DEFECTIVE USE STATEMENT—
Feb 17, 1994IUAFUSE AMENDMENT FILED—
Nov 16, 1993NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 24, 1993PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 23, 1993NPUBNOTICE OF PUBLICATION—
Jun 10, 1993CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 10, 1993DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance